Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether moderately ill Asian schizophrenic patients
can be switched from their previous antipsychotic medication to aripiprazole with minimal
adverse clinical consequences, and elucidate both pharmacokinetic and pharmacodynamic factors
associated with clinical efficacy of aripiprazole.
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
National Science Council, Taiwan Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan